CLINICAL_TRIALS
trial_result
· 2018-10-31
Clinical Trial Update: Eculizumab Pharmacokinetics/Pharmacodynamics Study in Pediatric/Adolescent Paroxysmal Nocturnal Hemoglobinuria (PNH) [Phase 4]
Summary
Phase 4 pharmacokinetics/pharmacodynamics study of eculizumab in pediatric/adolescent paroxysmal nocturnal hemoglobinuria has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Hemoglobinuria, Paroxysmal | Phase 4 | Status: COMPLETED | Results posted: 2018-10-31